Cargando…
ODP224 Metformin Associated Lactic Acidosis in a Nondiabetic Young Female
BACKGROUND: Metformin is the first line of treatment for patients with Diabetes Mellitus type 2. Despite multiple benefits, metformin is contraindicated in stage 4 renal disease due to an increased risk of metformin associated lactic acidosis (MALA). MALA is estimated to have a high mortality rate o...
Autores principales: | Saberi, Elnaz, Izkhakov, Neriy, Radpour, Omid, Vernetti, Nicholas, Nakhle, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624879/ http://dx.doi.org/10.1210/jendso/bvac150.675 |
Ejemplares similares
-
PSUN277 Symptomatic Hypoglycemia Associated with Over The Counter Supplement
por: Izkhakov, Neriy, et al.
Publicado: (2022) -
PSUN286 A Rare Case of Non-Islet Cell Tumor Hypoglycemia in Young Female With Metastatic Neuroendocrine Tumor
por: Zweibach, Eugenia, et al.
Publicado: (2022) -
LBODP034 Metformin Associated Lactic Acidosis, Rare But Real
por: Khalifa, Maram, et al.
Publicado: (2022) -
SAT136 Severe Lactic Acidosis Due To Metformin Use.
por: Khan, Areej
Publicado: (2023) -
SUN-683 Was Metformin the Culprit for This Lactic Acidosis?
por: Vemparala, Pranathi, et al.
Publicado: (2020)